Release 56
(Apr 24, 2025)
Gene search results:
Gene centric view
Trait centric view
Search:
Trait name:
Fat androstenone level
Ontology terms:
VT:1000444
,
tobemapped
99 genes are associated with this trait, with QTL/association found
ABLIM1: Actin binding LIM protein 1
evidenced by:
QTL:194745
;
QTL:194798
;
ACSL5: Acyl-CoA synthetase long chain family member 5
evidenced by:
QTL:194697
;
QTL:194710
;
QTL:194770
;
ADPRH: ADP-ribosylarginine hydrolase
evidenced by:
QTL:194714
;
AMPH: Amphiphysin
evidenced by:
QTL:194740
;
ANKFN1: Ankyrin repeat and fibronectin type III domain containing 1
evidenced by:
QTL:194727
;
ANKFY1: Ankyrin repeat and FYVE domain containing 1
evidenced by:
QTL:194759
;
APAF1: Apoptotic peptidase activating factor 1
evidenced by:
QTL:194780
;
ARPC1B: Actin related protein 2/3 complex subunit 1B
evidenced by:
QTL:194756
;
ATP2C2: ATPase secretory pathway Ca2+ transporting 2
evidenced by:
QTL:194713
;
BMP5: Bone morphogenetic protein 5
evidenced by:
QTL:194686
;
BRINP3: BMP/retinoic acid inducible neural specific 3
evidenced by:
QTL:194781
;
CASP2: Caspase 2
evidenced by:
QTL:194680
;
QTL:194681
;
CBLN4: Cerebellin 4 precursor
evidenced by:
QTL:194774
;
QTL:194784
;
CCDC84: Coiled-coil domain containing 84
evidenced by:
QTL:194794
;
CCL27: C-C motif chemokine ligand 27
evidenced by:
QTL:194741
;
QTL:194752
;
CCN4: Cellular communication network factor 4
evidenced by:
QTL:194718
;
CDH17: Cadherin 17
evidenced by:
QTL:194778
;
CDK5RAP2: CDK5 regulatory subunit associated protein 2
evidenced by:
QTL:194743
;
QTL:194744
;
CS: Citrate synthase
evidenced by:
QTL:220547
;
CST7: Cystatin F
evidenced by:
QTL:194689
;
QTL:194701
;
CYP1A2: Cytochrome P450, family 1, subfamily A, polypeptide 2
evidenced by:
QTL:194742
;
DENND11: DENN domain containing 11
evidenced by:
QTL:194709
;
DHX37: DEAH-box helicase 37
evidenced by:
QTL:194751
;
DMAC1: Distal membrane arm assembly complex 1
evidenced by:
QTL:194699
;
DPYD: Dihydropyrimidine dehydrogenase
evidenced by:
QTL:194748
;
DSG3: Desmoglein 3
evidenced by:
QTL:194724
;
EPHX2: Epoxide hydrolase 2
evidenced by:
QTL:194765
;
EPS8L3: EPS8 like 3
evidenced by:
QTL:194729
;
EXOSC9: Exosome component 9
evidenced by:
QTL:194721
;
EXTL3: Exostosin like glycosyltransferase 3
evidenced by:
QTL:194723
;
QTL:194777
;
FAM53C: Family with sequence similarity 53 member C
evidenced by:
QTL:194677
;
QTL:194678
;
QTL:194679
;
GABRB2: Gamma-aminobutyric acid type A receptor subunit beta2
evidenced by:
QTL:194758
;
GCM1: Glial cells missing homolog 1 (Drosophila)
evidenced by:
QTL:194734
;
GNMT: Glycine N-methyltransferase
evidenced by:
QTL:194716
;
QTL:194764
;
GRIK1: Glutamate ionotropic receptor kainate type subunit 1
evidenced by:
QTL:194703
;
HGSNAT: Heparan-alpha-glucosaminide N-acetyltransferase
evidenced by:
QTL:194787
;
QTL:194793
;
IDH3A: Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
evidenced by:
QTL:194670
;
QTL:194671
;
IDNK: IDNK gluconokinase
evidenced by:
QTL:194694
;
IFITM1: Interferon-induced transmembrane protein 1
evidenced by:
QTL:194768
;
QTL:194788
;
IFITM5: Interferon induced transmembrane protein 5
evidenced by:
QTL:194769
;
QTL:194789
;
KCNK2: Potassium two pore domain channel subfamily K member 2
evidenced by:
QTL:194725
;
QTL:194775
;
KRT4: Keratin 4
evidenced by:
QTL:194757
;
KRT8: Keratin 8
evidenced by:
QTL:194726
;
LIMK2: LIM domain kinase 2
evidenced by:
QTL:194688
;
LOC100516852: Radial spoke head 10 homolog B
evidenced by:
QTL:194760
;
LRFN2: Leucine rich repeat and fibronectin type III domain containing 2
evidenced by:
QTL:194738
;
LRRC8D: Leucine rich repeat containing 8 VRAC subunit D
evidenced by:
QTL:194728
;
QTL:194733
;
MAL2: Mal, T cell differentiation protein 2
evidenced by:
QTL:194730
;
QTL:194731
;
MARVELD2: MARVEL domain containing 2
evidenced by:
QTL:194676
;
MDFIC: MyoD family inhibitor domain containing
evidenced by:
QTL:194722
;
MIPEP: Mitochondrial intermediate peptidase
evidenced by:
QTL:194685
;
MMUT: Methylmalonyl-CoA mutase
evidenced by:
QTL:194762
;
MVP: Major vault protein
evidenced by:
QTL:194700
;
NDUFA10: NADH:ubiquinone oxidoreductase subunit A10
evidenced by:
QTL:194739
;
QTL:194776
;
OPN4: Opsin 4
evidenced by:
QTL:194797
;
P4HTM: Prolyl 4-hydroxylase, transmembrane
evidenced by:
QTL:194696
;
QTL:194707
;
PADI2: Peptidyl arginine deiminase 2
evidenced by:
QTL:194773
;
PAPPA: Pappalysin 1
evidenced by:
QTL:194692
;
PEMT: Phosphatidylethanolamine N-methyltransferase
evidenced by:
QTL:194719
;
PEX10: Peroxisomal biogenesis factor 10
evidenced by:
QTL:194799
;
PGGHG: Protein-glucosylgalactosylhydroxylysine glucosidase
evidenced by:
QTL:194766
;
QTL:194785
;
PHGDH: Phosphoglycerate dehydrogenase
evidenced by:
QTL:194712
;
QTL:194717
;
PKHD1: PKHD1 ciliary IPT domain containing fibrocystin/polyductin
evidenced by:
QTL:194782
;
PM20D2: Peptidase M20 domain containing 2
evidenced by:
QTL:194708
;
POLR1E: RNA polymerase I subunit E
evidenced by:
QTL:194702
;
QTL:194753
;
POLR3H: RNA polymerase III subunit H
evidenced by:
QTL:194783
;
PPARA: Peroxisome proliferator activated receptor alpha
evidenced by:
QTL:194749
;
PYGL: Glycogen phosphorylase L
evidenced by:
QTL:194754
;
RAB11FIP2: RAB11 family interacting protein 2
evidenced by:
QTL:194720
;
RAB11FIP5: RAB11 family interacting protein 5
evidenced by:
QTL:194790
;
QTL:194800
;
QTL:194792
;
RASSF4: Ras association domain family member 4
evidenced by:
QTL:194786
;
QTL:194791
;
RDH16: Retinol dehydrogenase 16
evidenced by:
QTL:194673
;
REEP5: Receptor accessory protein 5
evidenced by:
QTL:194683
;
QTL:194690
;
RGMB: Repulsive guidance molecule BMP co-receptor b
evidenced by:
QTL:194711
;
RNF181: Ring finger protein 181
evidenced by:
QTL:194747
;
QTL:194767
;
RNF4: Ring finger protein 4
evidenced by:
QTL:220545
;
SAMD15: Sterile alpha motif domain containing 15
evidenced by:
QTL:194698
;
SLA-DRB1: MHC class II histocompatibility antigen SLA-DRB1
evidenced by:
QTL:601
;
QTL:602
;
QTL:603
;
QTL:604
;
QTL:605
;
SLC22A1: Solute carrier family 22 member 1
evidenced by:
QTL:194684
;
SLC39A5: Solute carrier family 39 member 5
evidenced by:
QTL:220546
;
SLC6A19: Solute carrier family 6 member 19
evidenced by:
QTL:194750
;
QTL:194796
;
SLFN13: Schlafen family member 13
evidenced by:
QTL:194761
;
SMPD3: Sphingomyelin phosphodiesterase 3
evidenced by:
QTL:194736
;
SPHK2: Sphingosine kinase 2
evidenced by:
QTL:194695
;
SPHKAP: SPHK1 interactor, AKAP domain containing
evidenced by:
QTL:194795
;
SPO11: SPO11 initiator of meiotic double stranded breaks
evidenced by:
QTL:194674
;
QTL:194675
;
QTL:194682
;
SPOCK3: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3
evidenced by:
QTL:194715
;
SYNJ2: Synaptojanin 2
evidenced by:
QTL:194691
;
TAC3: Tachykinin 3
evidenced by:
QTL:194672
;
TARS2: Threonyl-tRNA synthetase 2, mitochondrial
evidenced by:
QTL:194732
;
TBCE: Tubulin folding cofactor E
evidenced by:
QTL:194687
;
QTL:194693
;
TDP2: Tyrosyl-DNA phosphodiesterase 2
evidenced by:
QTL:194735
;
TNFAIP8L2: TNF alpha induced protein 8 like 2
evidenced by:
QTL:194737
;
TRIB3: Tribbles pseudokinase 3
evidenced by:
QTL:194704
;
QTL:194705
;
TRPV2: Transient receptor potential cation channel subfamily V member 2
evidenced by:
QTL:194706
;
QTL:194772
;
TRPV6: Transient receptor potential cation channel subfamily V member 6
evidenced by:
QTL:194771
;
USH1C: USH1 protein network component harmonin
evidenced by:
QTL:194779
;
ZNF185: Zinc finger protein 185 with LIM domain
evidenced by:
QTL:194746
;
QTL:194755
;
ZNF662: Zinc finger protein 662
evidenced by:
QTL:194763
;
60 correlations are found involving
Fat androstenone level
Map them by chromosomes:
Chr.X
,
Chr.1
,
Chr.2
,
Chr.3
,
Chr.4
,
Chr.5
,
Chr.6
,
Chr.7
,
Chr.8
,
Chr.9
,
Chr.10
,
Chr.11
,
Chr.12
,
Chr.13
,
Chr.14
,
Chr.15
,
Chr.16
,
Chr.17
,
Chr.18
.
Download
to download the data displayed on this page in a tabulated .csv format.
© 2003-2025:
USA · USDA · NRPSP8 · Program to Accelerate Animal Genomics Applications
.
Contact:
Bioinformatics Team